BATF transgenic mice reveal a role for activator protein-1 in NKT cell development

Journal of Immunology

Volumn 170, Issue 5, 2003, Pages 2417-2426

  Williams, Kristi L ^a   Zullo, Alfred J ^a   Kaplan, Mark H ^b   Brutkiewicz, Randy R ^b   Deppmann, Christopher D ^a   Vinson, Charles ^c   Taparowsky, Elizabeth J ^a  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LEUCINE ZIPPER PROTEIN; PROTEIN BATF; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CYTOKINE PRODUCTION; FLOW CYTOMETRY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE; THYMUS; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

EID: 0037372554     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.5.2417     Document Type: Article

References (48)

1. Kuo, C. T., and J. M. Leiden. 1999. Transcriptional regulation of T lymphocyte development and function. Annu. Rev. Immunol. 17:149.
2. Foletta, V. C., D. H. Segal, and D. R. Cohen. 1998. Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukocyte Biol. 63:139.
3. Shaulian, E. and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell. Biol. 4:131.
4. Chen, D., and E. V. Rothenberg. 1993. Molecular basis for developmental changes in interleukin-2 gene inducibility. Mol. Cell. Biol. 13:228.
5. Rincón, M., and R. A. Flavell. 1994. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13:4370.
6. Rincón, M., and R. A. Flavell. 1996. Regulation of AP-1 and NFAT transcription factors during thymic selection of T cells. Mol. Cell. Biol. 16:1074.
7. Chen, F., D. Chen, and E. V. Rothenberg. 1999. Specific regulation of Fos family transcription factors in thymocytes at two developmental checkpoints. Int. Immunol. 11:677.
8. Chen, J., V. Stewart, G. Spyrou, F. Hilberg, E. F. Wagner, and F. W. Alt. 1994. Generation of normal T and B lymphocytes by c-jun deficient embryonic stem cells. Immunity 1:65.
9. Jain, J., E. A. Nalefski, P. G. McCaffrey, R. S. Johnson, B. M. Spiegelman, V. Papaioannou, and A. Rao. 1994. Normal peripheral T-cell function in c-Fos-deficient mice. Mol. Cell. Biol. 14:1566.
10. + thymocytes. Int. Immunol. 11:1203.
11. Dorsey, M. J., H-J. Tae, K. G. Sollenberger, N. T. Mascarenhas, L. M. Johansen, and, E. J. Taparowsky. 1995. B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. Oncogene 11:2255.
12. Echlin, D. R., H.-J. Tae, N. Mitin, and E. J. Taparowsky. 2000. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Oncogene 19:1752.
13. Williams, K. L., I. Nanda, G. E. Lyons, C. T. Kuo, M. Schmid, J. M. Leiden, M. H. Kaplan, and E. J. Taparowsky. 2001. Characterization of murine BATF: a negative regulator of activator protein-1 activity in the thymus. Eur. J. Immunol. 31:1620.
14. Garvin, A. M., K. M. Abraham, K. A. Forbush, A. G. Farr, B. L. Davison, and R. M. Perlmutter. 1990. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int. Immunol. 2:173.
15. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.
16. Godfrey, D. I., K. L. J. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today 21:573.
17. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557.
18. Chaffin, K. E., C. R. Beals, T. M. Wilkie, K. A. Forbush. M. I. Simon, and R. M. Perlmutter. 1990. Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J. 9:3821.
19. Mendiratta, S. K., W. D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6:469.
20. Ramocki, M. B., S. E. Johnson, M. A. White, C. L. Ashendel, S. F. Konieczny, and E. J. Taparowsky. 1997. Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis. Mol. Cell. Biol. 17:3547.
21. + T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179: 1285.
22. Hodge, M. R., A. M. Ranger, F. C. de la Brousse, T. Hoey, M. J. Grusby, and L. H. Glimcher. 1996. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4:397.
23. + T lymphocytes. Science 268:863.
24. Smiley, S. T., M. H. Kaplan, and M. J. Grusby. 1997. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275:977.
25. Zhang, S., N. W. Lukacs, V. A. Lawless, S. L. Kunkel, and M. H. Kaplan. 2000. Differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4. J. Immunol. 165:10.
26. + T cells. Eur. J. Immunol. 27: 1576.
27. + T cell development and early IL-4 production in CD1-deficient mice. Immunity 6:459.
28. lck with the pre-T cell receptor during thymocyte development. Eur. J. Immunol. 30:8.
29. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
30. + T cells. Annu. Rev. Immunol. 12:635.
31. Nishimura, T., H. Kitamura, K. Iwakabe, T. Yahata, A. Ohta, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, et al. 2000. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12:987.
32. Eberl, G., P. Brawand, and H. R. MacDonald. 2000. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30: 985.
33. Hammond, K. J. L., D. G. Pellicci, L. D. Poulton, O. V. Naidenko, A. A. Scalzo, A. G. Baxter, and D. I. Godfrey. 2001. CD1d restricted NKT cells: an interstrain comparison. J. Immunol. 167:1164.
34. 2-microglobulin-dependent surface expression of functional mouse CD1.1. J. Exp. Med. 182:1913.
35. Macián, F., C. López-Rodríguez, and A. Rao. 2001. Partners in transcription: NFAT and AP-1. Oncogene 20:2476.
36. Gapin, L., J. L. Matsuda, C. D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2:971.
37. Benlagha, K., T. Kyin, A. Beavis, L. Teyton and A. Bendelac. 2002. A thymic precursor to the NKT cell lineage. Science 296:553.
38. Honey, K., K. Benlagha, C. Beers, K. Forbush, L. Teyton, M. J. Kleijmeer, A. Y. Rudensky, and A. Bendelac. 2002. Thymocyte expression of cathepsin L is essential for NKT cell development. Nat. Immunol. 3:1069.
39. Carrozza, M. L., H. Jacobs, D. Acton, I. Verma, and A. Berns. 1997. Overexpression of the FosB2 gene in thymocytes causes aberrant development of T cells and thymic epithelial cells. Oncogene 14:1083.
40. Lehuen, A., O. Lantz, L. Beaudoin, V. Laloux, C. Carnaud, A. Bendelac, J. F. Bach, and R. C. Monteiro. 1998. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188:1831.
41. + cell development. J. Immunol. 159:5931.
42. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:771.
43. Gadue, P., N. Morton, and P. L. Stein. 1999. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J. Exp. Med. 190:1189.
44. Gadue, P., and P. L. Stein. 2002. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J. Immunol. 169:2397.
45. Eberl, G., B. Lowin-Kropf, and H. R. MacDonald. 1999. NKT cell development is selectively impaired in Fyn-deficient mice. J. Immunol. 163:4091.
46. Walunas, T. L., B. Wang, C. R. Wang, and J. M. Leiden. 2000. The Ets1 transcription factor is required for the development of NKT cells in mice. J. Immunol. 164:2857.
47. Bassuk, A. G., and J. M. Leiden. 1995. A direct physical association between ETS and AP-1 transcription factors in normal human T cells. Immunity 3:223.
48. MacDonald, H. R. 2000. CD1d-glycolipid tetramers: a new tool to monitor natural killer T cells in health and disease. J. Exp. Med. 192:F15.